5 Best One Dollar Stocks to Buy Today
Avenue Therapeutics, Inc. (NASDAQ:ATXI) is a specialty pharma firm that focuses on the development of products for intensive care.
Avenue Therapeutics Inc. (ATXI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.50 | 497 | $1,242.50 | 620 | 2024-09-30 | Filing | |
| $2.40 | 3 | $7.20 | 123 | 2024-09-27 | Filing | |
| $0.72 | 348,675 | $251,046.00 | 354,318 | 2023-09-08 | Filing | |
| $0.72 | 418,410 | $301,255.20 | 1,032,390 | 2023-09-08 | Filing | |
| $3.99 | 2,500 | $9,975.00 | 134,724 | 2021-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.00 | 23 | $46.00 | 97 | 2024-12-02 | Filing | |
| $2.24 | 61 | $136.64 | 559 | 2024-11-05 | Filing | |
| $0.14 | 20,000 | $2,800.00 | 80,000 | 2023-12-11 | Filing | |
| $0.14 | 128,000 | $17,920.00 | 147,000 | 2023-12-11 | Filing | |
| $0.14 | 126,000 | $17,640.00 | 215,800 | 2023-12-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is Avenue Therapeutics (ATXI) Stock a Buy For 2021?
Clark Street Value sold 2/3rds of its position in Avenue Therapeutics Inc. (NASDAQ:ATXI) stock.
Hedge Funds Watching Avenue Therapeutics, Inc. (ATXI) From Afar
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Billionaire Hedge Funds
